Cyclin-dependent kinases (cdks) and the DNA damage response: rationale for cdk inhibitor–chemotherapy combinations as an anticancer strategy for solid tumors

Author： Johnson Neil   Shapiro Geoffrey I  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.14, Iss.11, 2010-11, pp. : 1199-1212

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Opinion Paper: Targeting Multiple Cyclin-Dependent Kinases (CDKs): A New Strategy for Molecular Docking Studies

By  

Current Drug Targets, Vol. 17, Iss. 1, 2016-01 ,pp. : 2-2

Bentham Science Publishers

Access to resources Recommend Favorite

Advances on Cyclin-dependent Kinases (CDKs) as Novel Targets for Antiviral Drugs

By  

Current Drug Targets - Infectious Disorders, Vol. 5, Iss. 1, 2005-03 ,pp. : 29-37

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors of Cyclin-Dependent Kinases as Anti-Cancer Therapeutics

By  

Current Medicinal Chemistry, Vol. 7, Iss. 12, 2000-12 ,pp. : 1213-1245

Bentham Science Publishers

Access to resources Recommend Favorite

Cyclin-dependent kinases and stroke

By Park David S   Wang Fuhu   O’Hare Michael J  

Expert Opinion on Therapeutic Targets, Vol. 5, Iss. 5, 2001-10 ,pp. : 557-567

Informa Healthcare

Access to resources Recommend Favorite

Editorial: DNA Damage as a Strategy for Anticancer Chemotherapy

By  

Current Medicinal Chemistry, Vol. 24, Iss. 15, 2017-06 ,pp. : 1487-1487

Bentham Science Publishers

Access to resources Recommend Favorite